| Identification | Back Directory | [Name]
(S)-N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-Dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-hydroxypropanamide | [CAS]
23498-37-5 | [Synonyms]
T-2636F
Lankacidinol
Antibiotic T-2636F
(S)-N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-Dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-hydroxypropanamide
Propanamide, N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-hydroxy-, (2S)- | [Molecular Formula]
C25H35NO7 | [MOL File]
23498-37-5.mol | [Molecular Weight]
461.55 |
| Hazard Information | Back Directory | [Uses]
Lankacidinol (T-2636 F) is an antibiotic. Lankacidinol and its related metabolites 2,18-seco-lankacidinol A (1) and 2,18-seco-lankacidinol B (2) have significant biological activities and potential medicinal value. In addition, 2,18-seco-lankacidinol A exhibits potent antitumor activity. | [References]
[1] Studies on T-2636 antibiotics. II Isolation and chemical properties of T-2636 antibiotics |
|
|